To investigate the validity of these assessments, we further compared the cathepsin B and S cleavage prediction data with those reported from IGHV-derived peptides eluted from HLA class II on lymphoma cells from two patients with mantle cell lymphoma [33]. This evidence concerns the gene CTSB and lymphoma.